Eczacıbaşı-Monrol is an innovative, international supplier of radiopharmaceuticals for diagnosis and treatment in nuclear medicine. The company exports to more than 50 countries around the globe and has GMP certified manufacturing sites and operational projects in different regions. Eczacıbaşı-Monrol produces cGMP compliant radiopharmaceuticals for diagnosis and treatment in seven world-class production facilities with 10 cyclotrons, two SPECT production lines, and one SPECT EU release site. Eczacıbaşı-Monrol is headquartered in Istanbul and delivers high quality, customer-oriented service to nuclear medicine centres through more than 30 distributors.